tradingkey.logo

tradingkey.logo
怜玢


Biofrontera Inc

BFRI
りォッチリストに远加
0.800USD
-0.189-19.08%
終倀 05/15, 16:00ET15分遅れの株䟡
10.24M時䟡総額
損倱額盎近12ヶ月PER


詳现情報 Biofrontera Inc 䌁業名

Biofrontera Inc. is a biopharmaceutical company. The Company specializes in the development and commercialization of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT). The PDT treatment is used for the lesion-directed and field-directed treatment of actinic keratoses of mild-to-moderate severity on the face and scalp. The Company’s primary licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (the RhodoLED Lamps), are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions. The Company commercializes the drug-device combination Ameluz with the RhodoLED lamp series for PDT of AK, pre-cancerous skin lesions which may progress to invasive skin cancers. Its belixos ACTIVE CARE is a skin-soothing care foam for irritated and itchy skin, which can be used as basic care for atopic dermatitis and psoriasis as well as for soothing intensive care for everyday skin problems.

Biofrontera Incの䌁業情報


䌁業コヌドBFRI
䌚瀟名Biofrontera Inc
䞊堎日Oct 14, 2021
最高経営責任者「CEO」Luebbert (Hermann)
埓業員数92
蚌刞皮類Ordinary Share
決算期末Oct 14
本瀟所圚地120 Presidential Way,
郜垂WOBURN
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号01801
電話番号17812451325
りェブサむトhttps://www.biofrontera-us.com/
䌁業コヌドBFRI
䞊堎日Oct 14, 2021
最高経営責任者「CEO」Luebbert (Hermann)

Biofrontera Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Prof. Dr. Hermann Luebbert, Ph.D.
Prof. Dr. Hermann Luebbert, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
290.21K
+47.38%
Mr. Eugene Frederick (Fred) Leffler, III
Mr. Eugene Frederick (Fred) Leffler, III
Chief Financial Officer
Chief Financial Officer
175.00K
+50.00%
Dr. John J. Borer, III
Dr. John J. Borer, III
Independent Director
Independent Director
--
--
Dr. Beth J. Hoffman, Ph.D.
Dr. Beth J. Hoffman, Ph.D.
Independent Director
Independent Director
--
--
Mr. Kevin D. Weber
Mr. Kevin D. Weber
Independent Director
Independent Director
--
--
Dr. Heikki Lanckriet, Ph.D.
Dr. Heikki Lanckriet, Ph.D.
Director
Director
--
--
Mr. George Jones
Mr. George Jones
Chief Commercial Officer
Chief Commercial Officer
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Prof. Dr. Hermann Luebbert, Ph.D.
Prof. Dr. Hermann Luebbert, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
290.21K
+47.38%
Mr. Eugene Frederick (Fred) Leffler, III
Mr. Eugene Frederick (Fred) Leffler, III
Chief Financial Officer
Chief Financial Officer
175.00K
+50.00%
Dr. John J. Borer, III
Dr. John J. Borer, III
Independent Director
Independent Director
--
--
Dr. Beth J. Hoffman, Ph.D.
Dr. Beth J. Hoffman, Ph.D.
Independent Director
Independent Director
--
--
Mr. Kevin D. Weber
Mr. Kevin D. Weber
Independent Director
Independent Director
--
--
Dr. Heikki Lanckriet, Ph.D.
Dr. Heikki Lanckriet, Ph.D.
Director
Director
--
--

収益内蚳

FY2025
FY2024
FY2023
FY2022
FY2021
䌚瀟から関連デヌタがただ開瀺されおいたせん。
地域別USD
䌚瀟名
収益
比率
United States
41.70M
0.00%
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: Thu, May 14
曎新時刻: Thu, May 14
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Rosalind Advisors, Inc.
9.50%
AIGH Capital Management, LLC.
5.80%
Hewlett Fund, L.P.
3.93%
Biofrontera AG
3.33%
Lytton (Laurence W)
2.55%
他の
74.88%
株䞻統蚈
株䞻統蚈
比率
Rosalind Advisors, Inc.
9.50%
AIGH Capital Management, LLC.
5.80%
Hewlett Fund, L.P.
3.93%
Biofrontera AG
3.33%
Lytton (Laurence W)
2.55%
他の
74.88%
皮類
株䞻統蚈
比率
Hedge Fund
12.10%
Corporation
7.26%
Individual Investor
6.43%
Private Equity
6.29%
Investment Advisor/Hedge Fund
2.37%
Investment Advisor
1.71%
Research Firm
0.28%
Venture Capital
0.16%
他の
63.40%

機関投資家保有株


曎新時刻: Wed, Apr 1
曎新時刻: Wed, Apr 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2026Q1
37
2.75M
22.90%
-276.67K
2025Q4
34
2.85M
28.39%
--
2025Q3
35
2.85M
24.13%
+509.58K
2025Q2
38
2.48M
28.99%
+6.08K
2025Q1
43
1.91M
35.97%
-1.28M
2024Q4
42
2.24M
20.22%
+365.98K
2024Q3
37
1.95M
35.26%
+44.70K
2024Q2
40
1.95M
40.02%
-47.81K
2024Q1
39
1.85M
15.80%
+1.04M
2023Q4
36
279.45K
16.52%
+54.33K
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Rosalind Advisors, Inc.
1.14M
9.79%
--
--
Dec 31, 2025
AIGH Capital Management, LLC.
696.57K
5.98%
-102.15K
-12.79%
Dec 31, 2025
Hewlett Fund, L.P.
472.22K
4.05%
-78.00K
-14.18%
Dec 03, 2025
Biofrontera AG
400.00K
3.43%
--
--
Sep 16, 2025
Lytton (Laurence W)
306.70K
2.63%
-228.98K
-42.75%
Mar 31, 2025
Armistice Capital LLC
291.15K
2.5%
+141.15K
+94.10%
Sep 30, 2024
Luebbert (Hermann)
290.21K
2.49%
+137.50K
+90.04%
Mar 05, 2026
Worth Venture Partners, LLC
218.64K
1.88%
-28.69K
-11.60%
Dec 31, 2025
Leffler (Eugene Frederick)
175.00K
1.5%
+87.50K
+100.00%
Mar 05, 2026
Geode Capital Management, L.L.C.
65.68K
0.56%
+23.07K
+54.16%
Dec 31, 2025
詳现を芋る

関連ETF


銘柄名
比率
デヌタなし

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
Jul 03, 2023
Merger
20→1
Jul 03, 2023
Merger
20→1
Jul 03, 2023
Merger
20→1
Jul 03, 2023
Merger
20→1
日付
配圓萜ち日
皮類
比率
Jul 03, 2023
Merger
20→1
Jul 03, 2023
Merger
20→1
Jul 03, 2023
Merger
20→1
Jul 03, 2023
Merger
20→1
KeyAI
î™